Literature DB >> 17173072

Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma.

J Kluiver1, A van den Berg, D de Jong, T Blokzijl, G Harms, E Bouwman, S Jacobs, S Poppema, B-J Kroesen.   

Abstract

BIC is a primary microRNA (pri-miR-155) that can be processed to mature miR-155. In this study, we show the crucial involvement of protein kinase C (PKC) and nuclear factor-kappaB (NF-kappaB) in the regulation of BIC expression upon B-cell receptor triggering. Surprisingly, Northern blot analysis did not reveal any miR-155 expression upon induction of BIC expression in the Burkitt lymphoma-derived Ramos cell line, whereas other microRNAs were clearly detectable. Ectopic expression of BIC in Ramos and HEK293 cells resulted in miR-155 expression in HEK293, but not in Ramos cells, suggesting a specific block of BIC to miR-155 processing in Ramos. In line with the results obtained with Ramos, lack of miR-155 expression after induction of BIC expression was also observed in other Burkitt lymphoma cell lines, indicating a generic and specific blockade in the processing of BIC in Burkitt lymphoma. In contrast, induction of BIC expression in normal tonsillar B cells resulted in very high levels of miR-155 expression and induction of BIC expression in Hodgkin's lymphoma cell lines. It also resulted in elevated levels of miR-155. Our data provide evidence for two levels of regulation for mature miR-155 expression: one at the transcriptional level involving PKC and NF-kappaB, and one at the processing level. Burkitt lymphoma cells not only express low levels of BIC, but also prevent processing of BIC via an, as yet, unknown mechanism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17173072     DOI: 10.1038/sj.onc.1210147

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  59 in total

1.  Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation.

Authors:  Zhong-Bo Han; Hong-Yuan Chen; Jun-Wei Fan; Jun-Yi Wu; Hua-Mei Tang; Zhi-Hai Peng
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-10       Impact factor: 4.553

Review 2.  Mechanisms of control of microRNA biogenesis.

Authors:  Brandi N Davis-Dusenbery; Akiko Hata
Journal:  J Biochem       Date:  2010-09-09       Impact factor: 3.387

3.  MicroRNAs, macrocontrol: regulation of miRNA processing.

Authors:  Izabella Slezak-Prochazka; Selvi Durmus; Bart-Jan Kroesen; Anke van den Berg
Journal:  RNA       Date:  2010-04-27       Impact factor: 4.942

4.  IL-10 inhibits miR-155 induction by toll-like receptors.

Authors:  Claire E McCoy; Frederick J Sheedy; Joseph E Qualls; Sarah L Doyle; Susan R Quinn; Peter J Murray; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2010-04-30       Impact factor: 5.157

Review 5.  Complex regulation and function of activation-induced cytidine deaminase.

Authors:  Janet Stavnezer
Journal:  Trends Immunol       Date:  2011-04-13       Impact factor: 16.687

Review 6.  Shhh! Silencing by microRNA-155.

Authors:  Grace Teng; F Nina Papavasiliou
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-03-12       Impact factor: 6.237

7.  Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence.

Authors:  Fang Lu; Andreas Weidmer; Chang-Gong Liu; Stefano Volinia; Carlo M Croce; Paul M Lieberman
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

Review 8.  Regulation of mammalian microRNA processing and function by cellular signaling and subcellular localization.

Authors:  Neil R Smalheiser
Journal:  Biochim Biophys Acta       Date:  2008-04-08

Review 9.  MicroRNAs in cancer.

Authors:  Yong Sun Lee; Anindya Dutta
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

10.  Aging differentially affects human skeletal muscle microRNA expression at rest and after an anabolic stimulus of resistance exercise and essential amino acids.

Authors:  Micah J Drummond; John J McCarthy; Christopher S Fry; Karyn A Esser; Blake B Rasmussen
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-30       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.